Poncirin
CAS No. 14941-08-3
Poncirin ( —— )
产品货号. M18052 CAS No. 14941-08-3
Poncirin 对人胃癌细胞 SGC-791 的生长具有显着的体外抑制作用,且呈剂量依赖性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥833 | 有现货 |
|
| 5MG | ¥1216 | 有现货 |
|
| 10MG | ¥1786 | 有现货 |
|
| 25MG | ¥2911 | 有现货 |
|
| 50MG | ¥4073 | 有现货 |
|
| 100MG | ¥5553 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Poncirin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Poncirin 对人胃癌细胞 SGC-791 的生长具有显着的体外抑制作用,且呈剂量依赖性。
-
产品描述Poncirin shows a significant in vitro inhibitory effect on the growth of the human gastric cancer cells, SGC-791, in a dose-dependent manner. Poncirin prevents adipogenesis, enhances osteoblast differentiation in mesenchymal stem cellsincreased bone mineral density, and improves trabecular microarchitecture likely reflect increases bone formation and decreases bone resorption in GIO mice.
-
体外实验——
-
体内实验Poncirin (intraperitoneal administration; 30 mg/kg) markedly reduces the pain behavior in both acetic acid-induced visceral pain and formalin-induced tonic pain models inComplete Freund’s Adjuvant (CFA)-induced inflammatory pain model.
-
同义词——
-
通路MAPK/ERK Signaling
-
靶点ERK
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number14941-08-3
-
分子量594.56
-
分子式C28H34O14
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (168.19 mM)
-
SMILESCC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)OC)O)CO)O)O)O)O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
021-51111890
购物车()
sales@molnova.cn

